INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$36.9M

$36,854,166

View Raw Line-Items
Live Feed: 2026-03-11
NAMS S
NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter • Officer • Chief Scientific Officer
10b5-1 SellΔOwn -59.4%
2026-03-09 $3,071,679Large
View Form 4 →
NAMS X
NewAmsterdam Pharma Co N.V.
LANGE LOUIS G • Director
Other
2026-03-09 $513,118
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter • Officer • Chief Scientific Officer
10b5-1 SellΔOwn -57.6%
2026-03-06 $2,853,840Large
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
LANGE LOUIS G • Director
Discretionary Sell
2026-03-06 $828,950
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter • Officer • Chief Scientific Officer
10b5-1 SellΔOwn -60.1%
2026-03-05 $3,165,350Large
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
Davidson Michael H. • CEO
Discretionary SellΔOwn -71.8%
2026-03-02 $14,753,258MEGA
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
Davidson Michael H. • CEO
10b5-1 Sell
2026-02-26 $6,179,974Whalex2
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
Davidson Michael H. • CEO
10b5-1 Sell
2026-02-25 $2,056,174Largex3
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
Davidson Michael H. • CEO
10b5-1 Sell
2026-02-24 $2,338,943Largex2
View Form 4 →
NAMS S
NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter • Officer • Chief Scientific Officer
Discretionary SellΔOwn -14.8%
2026-02-20 $1,605,998Largex2
View Form 4 →